Murine Rankl-/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector
- PMID: 28100034
- DOI: 10.1002/stem.2574
Murine Rankl-/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector
Abstract
Autosomal recessive osteopetrosis (ARO) is a severe bone disease characterized by increased bone density due to impairment in osteoclast resorptive function or differentiation. Hematopoietic stem cell transplantation is the only available treatment; however, this therapy is not effective in RANKL-dependent ARO, since in bone this gene is mainly expressed by cells of mesenchymal origin. Of note, whether lack of RANKL production might cause a defect also in the bone marrow (BM) stromal compartment, possibly contributing to the pathology, is unknown. To verify this possibility, we generated and characterized BM mesenchymal stromal cell (BM-MSC) lines from wild type and Rankl-/- mice, and found that Rankl-/- BM-MSCs displayed reduced clonogenicity and osteogenic capacity. The differentiation defect was significantly improved by lentiviral transduction of Rankl-/- BM-MSCs with a vector stably expressing human soluble RANKL (hsRANKL). Expression of Rankl receptor, Rank, on the cytoplasmic membrane of BM-MSCs pointed to the existence of an autocrine loop possibly activated by the secreted cytokine. Based on the close resemblance of RANKL-defective osteopetrosis in humans and mice, we expect that our results are also relevant for RANKL-dependent ARO patients. Data obtained in vitro after transduction with a lentiviral vector expressing hsRANKL would suggest that restoration of RANKL production might not only rescue the defective osteoclastogenesis of this ARO form, but also improve a less obvious defect in the osteoblast lineage, thus possibly achieving higher benefit for the patients, when the approach is translated to clinics. Stem Cells 2017;35:1365-1377.
Keywords: Bone; Differentiation; Lentiviral transduction; Mesenchymal stromal cell; Osteopetrosis; Rankl.
© 2017 AlphaMed Press.
Similar articles
-
Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation.Stem Cell Res Ther. 2024 Jul 6;15(1):203. doi: 10.1186/s13287-024-03803-3. Stem Cell Res Ther. 2024. PMID: 38971808 Free PMC article.
-
Ginkgo biloba extract promotes osteogenic differentiation of human bone marrow mesenchymal stem cells in a pathway involving Wnt/β-catenin signaling.Pharmacol Res. 2015 Jul;97:70-8. doi: 10.1016/j.phrs.2015.04.004. Epub 2015 Apr 23. Pharmacol Res. 2015. PMID: 25917209
-
Decreased osteogenesis in mesenchymal stem cells derived from the aged mouse is associated with enhanced NF-κB activity.J Orthop Res. 2017 Feb;35(2):281-288. doi: 10.1002/jor.23270. Epub 2016 May 18. J Orthop Res. 2017. PMID: 27105133
-
Isolation and characterization of primary bone marrow mesenchymal stromal cells.Ann N Y Acad Sci. 2016 Apr;1370(1):109-18. doi: 10.1111/nyas.13102. Ann N Y Acad Sci. 2016. PMID: 27270495 Review.
-
RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.Clin Dev Immunol. 2013;2013:412768. doi: 10.1155/2013/412768. Epub 2013 May 15. Clin Dev Immunol. 2013. PMID: 23762088 Free PMC article. Review.
Cited by
-
RANKL biology.Bone. 2022 Jun;159:116353. doi: 10.1016/j.bone.2022.116353. Epub 2022 Feb 16. Bone. 2022. PMID: 35181574 Free PMC article. Review.
-
Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation.Stem Cell Res Ther. 2024 Jul 6;15(1):203. doi: 10.1186/s13287-024-03803-3. Stem Cell Res Ther. 2024. PMID: 38971808 Free PMC article.
-
RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation.Bone Res. 2018 Nov 27;6:34. doi: 10.1038/s41413-018-0035-6. eCollection 2018. Bone Res. 2018. PMID: 30510839 Free PMC article.
-
The RANKL-RANK Axis: A Bone to Thymus Round Trip.Front Immunol. 2019 Mar 29;10:629. doi: 10.3389/fimmu.2019.00629. eCollection 2019. Front Immunol. 2019. PMID: 30984193 Free PMC article. Review.
-
Oral microbiota-host interaction: the chief culprit of alveolar bone resorption.Front Immunol. 2024 Feb 22;15:1254516. doi: 10.3389/fimmu.2024.1254516. eCollection 2024. Front Immunol. 2024. PMID: 38455060 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases